[Expert Solution]: Which of the following is TRUE regarding…

Which of the following is TRUE regarding FDA drug approvals after review of safety data from clinical trials? Question 4 options: The FDA did not approve droxidopa for orthostatic hypotension even though it was very effective because there were other, safer, drugs on the market for treating this condition New drugs for very rare or life-threatening diseases undergo more extensive safety studies before FDA approval than drugs that treat chronic diseases The FDA approved flibanserin, a drug for female libido, even though it causes severe hypotension because a popular social campaign protested Torcetrapib, a drug for lowering cholesterol, was approved by the FDA even though it caused increased adverse cardiac events because it was highly effective All of the above are true